0
Onconova Therapeutics, Inc.
- 11-50 Employees
- Based in Newtown, Pennsylvania
Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). Rigosertib, Onconova's lead candidate, is a proprietary Phase 3 small molecule agent, which the Company believes blocks cellular signaling by targeting RAS effector pathways.
Onconova Therapeutics, Inc.
Most Recent Annual Report
Onconova Therapeutics, Inc. does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
